Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5Neoplasm Metastasis 2Vomiting 1Urinary Bladder Neoplasms 1TP53 Y220C Mutation 1Solid Tumors 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Nausea 1Myofibroma 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Carcinoma 1Breast Neoplasms 1Advanced Solid Tumors 1Advanced Cancer 1Adenocarcinoma of Lung 1

Interventions

casopitant 2Granisetron 2Cyclophosphamide 2fosaprepitant 1Tablets 1Methadone 1Injections, Intravenous 1Dronabinol 1Docetaxel 1Cannabidiol 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Nausea × Tablets × Clear all
NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed
50 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡